Basal-Like Breast Carcinoma
specificA biologic subset of breast carcinoma defined by high expression of genes characteristic of basal epithelial cells, including KRT5 and KRT17, annexin 8, CX3CL1, and TRIM29, and usually by lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It is the most common subtype of breast cancer associated with BRCA1 mutations, and is associated with a poor prognosis.
4
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Basal-Like Breast Carcinoma(4)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | 62.5 |
| 2 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 62.5 |
| 3 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive | 62.5 |
| 4 | Penn State Cancer InstituteHershey, PA | 62.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →